(DDS) in India: a Screening Tool to Identify Prediabetes & Undiagnosed

Status Not yet recruiting

Clinical Trial Summary

This study is conducted to evaluate validity of Diabetes Risk Assessment in Dentistry Score (DDS) in Indian population as a screening tool to identify patients with prediabetes and undiagnosed type 2 diabetes in dental setting. The DDS score of the patient will be correlated with the HbA1c levels and periodontal status of the patient. Such a study has been conducted in Germany but none has been validated in Indian population. Hence this study aims to assess the performance of DDS screening tool in Indian population.

Clinical Trial Description

BACKGROUND- Most of the models for T2DM risk assessment exist for use in medical settings and include data which is commonly unavailable to dentists. To overcome the limitation of applicability of existing diabetes-risk assessment tools in dental settings, the Diabetes Risk Assessment in Dentistry Score (DDS) was developed utilizing measures routinely available to dentists. It has been developed and validated in a German population and found to perform broadly at par with those validated for use in medical settings. RATIONALE-Models developed in a specific population need to be validated in other populations before they can be adopted. The DDS screening tool has not been validated in Indian population till date. OBJECTIVES- To assess performance of DDS screening tool in predicting the risk of prediabetes and type 2 diabetes mellitus among individuals seeking dental consultation in Indian population. METHODS-The study participants will include individuals seeking dental consultation at a university teaching hospital in India. All participants will undergo DDS risk-assessment followed by measurement of serum HbA1c levels to establish diagnosis of health, prediabetes or undiagnosed T2DM. EXPECTED OUTCOMES-It is expected that the DDS screening model performs well in Indian population, with scope for incorporation of the model during regular dental visits. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06453278
Study type	Observational
Source	Postgraduate Institute of Dental Sciences Rohtak
Contact	ADITI SANGWAN, MDS
Phone	09996002408
Email	aditidalal86@yahoo.co.in
Status	Not yet recruiting
Phase
Start date	September 2024
Completion date	April 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04712630` - Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft	N/A
Completed	`NCT06127069` - Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device	N/A
Completed	`NCT04964167` - Indocyanine-green Mediated Photosensitizer VS Aloe Vera Gel: Adjunct Therapy to Scaling and Root Planing in Patients With Chronic Periodontitis	Phase 4
Completed	`NCT05906797` - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.	N/A
Recruiting	`NCT03997552` - NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration	N/A
Completed	`NCT05530252` - Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis	Phase 4
Completed	`NCT04881357` - Antiplaque/Antigingivitis Effect of Lacer Oros Integral	N/A
Recruiting	`NCT03790605` - A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis	Phase 3
Enrolling by invitation	`NCT04971174` - Outcomes of Periodontal Regenerative Treatment
Not yet recruiting	`NCT05568290` - Interleukin-38 Levels in Individuals With Periodontitis
Completed	`NCT04383561` - Relationship Between LRG and Periodontal Disease	N/A
Recruiting	`NCT03997578` - Non-incised Papillae Surgical Approach (NIPSA) and Connective Tissue Graft Plus Emdogain for Periodontal Defects	N/A
Completed	`NCT03901066` - Smoking Dependence and Periodontitis
Enrolling by invitation	`NCT04956211` - Periodontal Treatment and Ischemic Stroke	N/A
Recruiting	`NCT05971706` - Ozone Application in Periodontal Treatment	N/A
Recruiting	`NCT06099574` - A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
Completed	`NCT04402996` - Meteorin-like Levels in Individuals With Periodontitis
Active, not recruiting	`NCT05311657` - Oral Health and Severe COPD
Not yet recruiting	`NCT05643287` - The Effect of Time on the Outcome of Periodontal Treatment.	N/A
Completed	`NCT02835898` - Epigenetics and Periodontal Treatment	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

(DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms